IDEAS home Printed from https://ideas.repec.org/a/adp/joroaj/v13y2018i3p48-54.html
   My bibliography  Save this article

Treatment Efficacy of Celecoxib and Diclofenac Sodium in Rheumatoid Arthritis A Review

Author

Listed:
  • A N F Fasmina

    (Department of Medical laboratory Science, Faculty of Allied Health Sciences, University of Peradeniya, Srilanka)

  • R A M Rafeek

    (Department of Microbiology, Faculty of Medicine, University of Peradeniya, Srilanka)

Abstract

Administrations of drugs that reduce pain and inflammation in Rheumatoid Arthritis (RA) have resulted in the experience of adverse effects. It is important to identify most suitable drug with increased treatment efficacy and reduced adverse effects for improved quality of life. RA is an inflammatory condition that affects joints resulting in chronic pain. Due to pain and stiffness of joints, the affected have a reduced quality of life. NSAIDs are commonly administered to reduce the pain and stiffness of joints. The most commonly prescribed drugs are Celecoxib and Diclofenac Sodium which are considered in this study. This study aims to determine the suitability and effectiveness of the drugs Celecoxib and Diclofenac Na in patients having rheumatoid arthritis in terms of efficacy and tolerance. This is a systematic review for which, using Cochrane review, Google Scholar and PubMed, 5 randomized control trials were chosen. According to this study, the treatment efficacy of both the drugs was similar in reducing pain and inflammation. But it is revealed that Celecoxib had lower probability of developing GI ulcers when compared to Diclofenac Na.

Suggested Citation

  • A N F Fasmina & R A M Rafeek, 2018. "Treatment Efficacy of Celecoxib and Diclofenac Sodium in Rheumatoid Arthritis A Review," Orthopedics and Rheumatology Open Access Journals, Juniper Publishers Inc., vol. 13(3), pages 48-54, December.
  • Handle: RePEc:adp:joroaj:v:13:y:2018:i:3:p:48-54
    DOI: 10.19080/OROAJ.2018.13.555861
    as

    Download full text from publisher

    File URL: https://juniperpublishers.com/oroaj/pdf/OROAJ.MS.ID.555861.pdf
    Download Restriction: no

    File URL: https://juniperpublishers.com/oroaj/OROAJ.MS.ID.555861.php
    Download Restriction: no

    File URL: https://libkey.io/10.19080/OROAJ.2018.13.555861?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:adp:joroaj:v:13:y:2018:i:3:p:48-54. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Robert Thomas (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.